文献速递乳房整形与再造

吲哚菁绿血管造影在乳房再造中的应用:110,320例患者的全国性结局与费用分析

Indocyanine Green Angiography Use in Breast Reconstruction: A National Analysis of Outcomes and Cost in 110,320 Patients.
PubMed 文献 · Plast Reconstr Surg · 2018-01-01

该研究利用2012至2014年HCUP全国住院患者样本,分析110,320例乳房再造患者中吲哚菁绿血管造影的使用趋势与结局。使用率从2012年750例(1.9%)增至2013年1275例(3.7%),2014年数据未单独报告。使用吲哚菁绿血管造影与清创几率增加相关(OR 1.404,95%CI 1.201-1.640,p<0.001)。

要点

  • 2012至2014年110,320例乳房再造中,3315例(3.0%)使用吲哚菁绿血管造影,107,005例(97.0%)未使用。
  • 使用率从2012年750例(1.9%)增至2013年1275例(3.7%),p<0.001。
  • 使用吲哚菁绿血管造影与清创几率增加相关(OR 1.404,95%CI 1.201-1.640,p<0.001)。

核心结论

  • 吲哚菁绿血管造影在乳房再造中的使用近年增加,并与较高的清创率相关。
  • 这些清创率可能反映临床医生在决定是否清创组织时的趋势变化。

研究设计与样本

  • 利用2012至2014年医疗成本与利用项目全国住院患者样本(HCUP-NIS)的回顾性分析,共纳入110,320例乳房再造患者。

主要发现

  • 110,320例乳房再造患者中,107,005例(97.0%)未使用吲哚菁绿血管造影,3315例(3.0%)使用。
  • 使用率从2012年750例(1.9%)增至2013年1275例(3.7%),p<0.001。
  • 吸烟者(p=0.018)、高血压患者(p=0.046)、肥胖患者(p<0.001)及合并症指数较高者(p<0.001)更可能接受吲哚菁绿血管造影。
  • 自体组织再造较组织扩张器再造更常联合使用吲哚菁绿血管造影(4.5% vs 2.1%,p<0.001)。
  • 使用吲哚菁绿血管造影与清创几率增加显著相关(OR 1.404,95%CI 1.201-1.640,p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indocyanine green angiography has gained popularity in breast reconstruction for its ability to assess mastectomy skin and tissue flap viability. The authors aim to analyze trends and outcomes associated with indocyanine green angiography use in breast reconstruction. METHODS: Using 2012 to 2014 data from the Healthcare Cost and Utilization Project National Inpatient Sample, Agency for Healthcare Research and Quality, the authors identified breast reconstructions performed with or without indocyanine green angiography use. Trends over time were assessed using the Cochran-Armitage test. Outcomes were assessed using logistic regression and generalized linear modeling. RESULTS: Over the study period, 110,320 patients underwent breast reconstruction: 107,005 (97.0 percent) without and 3315 (3.0 percent) with indocyanine green angiography use. Usage increased over time: 750 patients (1.9 percent) in 2012, increasing to 1275 patients (3.7 percent) in 2013 (p < 0.001). Smokers (p = 0.018), hypertensive patients (p = 0.046), obese patients (p < 0.001), and those with a higher comorbidity index (p < 0.001) were more likely to undergo indocyanine green angiography. Autologous reconstruction was more frequently combined with its use compared with tissue expander reconstruction (4.5 percent versus 2.1 percent; p < 0.001). There was a significant increase in the odds of débridement associated with its use (OR, 1.404; p < 0.001; 95 percent CI, 1.201 to 1.640). CONCLUSIONS: Indocyanine green angiography use in breast reconstruction has increased in recent years and is associated with higher débridement rates. These rates may indicate changing trends for clinicians when deciding whether to débride tissue during breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Chattha A, Bucknor A, Chen AD, et al. Indocyanine Green Angiography Use in Breast Reconstruction: A National Analysis of Outcomes and Cost in 110,320 Patients. Plast Reconstr Surg. 2018. PMID: 29240640. doi:10.1097/PRS.0000000000004195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。